Pharmaceuticals

Subcutaneous Immunoglobulin (SCIG) Industry Insights: Market Forecast to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Subcutaneous Immunoglobulin (SCIG) Market Size Likely To Evolve From 2025 Through 2034?

The subcutaneous immunoglobulin (SCIG) market has seen swift expansion in recent years. It is anticipated to increase from $12.72 billion in 2024 to $14.39 billion in 2025, progressing at a compound annual growth rate (CAGR) of 13.1%. In prior periods, this growth was primarily driven by the rising occurrence of immunodeficiency disorders, a growing patient preference for home-based care options, enhanced treatment effectiveness, increased awareness and diagnosis rates, and the implementation of supportive reimbursement policies.

The market size for subcutaneous immunoglobulin (SCIG) is projected for significant expansion over the coming years. It is expected to reach $23.23 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.7%. This anticipated growth during the forecast period is primarily fueled by the increasing occurrence of neurological disorders and autoimmune diseases, coupled with heightened awareness and acceptance of immunoglobulin therapy. Furthermore, broadening applications in neurology and dermatology, along with the expansion of healthcare facilities, contribute to this trend. Key developments anticipated for the forecast period include advancements in drug delivery systems, a rising demand for home infusion therapies, breakthroughs in antibody therapy, novel approaches in formulations, and continued innovations in SCIG.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15935&type=smp

Which Industry Drivers Are Expected To Accelerate The Subcutaneous Immunoglobulin (SCIG) Market From 2025 To 2029?

The rising occurrence of secondary immunodeficiency conditions is anticipated to fuel the expansion of the subcutaneous immunoglobulin market in the future. These diseases involve an immune system that is diminished or impaired due to factors external to the immune system’s primary function. Several elements contribute to the commonness of secondary immunodeficiency diseases, including an aging populace, the application of immunosuppressive therapies, and exposure to environmental toxins. Subcutaneous immunoglobulin treatment delivers antibodies that fortify a compromised immune system, particularly in long-term illnesses like HIV or autoimmune conditions, effectively averting infections and bolstering immune functionality throughout therapy. As an illustration, the UK Health Security Agency, a UK-based government agency, stated in October 2023 that England saw 3,805 new HIV diagnoses in 2022, marking a 22% increase compared to the year before. Consequently, the growing incidence of secondary immunodeficiency diseases is acting as a catalyst for the growth of the subcutaneous immunoglobulin market.

What Are The Major Segments Identified In The Subcutaneous Immunoglobulin (SCIG) Market?

The subcutaneous immunoglobulin (scig) market covered in this report is segmented –

1) By Product Type: Immunoglobulin A (IgA), Immunoglobulin G (IgG), Immunoglobulin M (IgM)

2) By Application: Primary Immunodeficiency Disorders, Autoimmune Diseases, Neurological Disorders, Other Applications

3) By End-Use: Clinics, Hospitals, Homecare, Other End-Uses

Subsegments:

1) By Immunoglobulin A (IgA): IgA1, IgA2

2) By Immunoglobulin G (IgG): IgG1, IgG2, IgG3, IgG4

3) By Immunoglobulin M (IgM): Pentameric IgM, Hexameric IgM

Which Competitive Trends Are Defining The Subcutaneous Immunoglobulin (SCIG) Market Structure?

Key players in the subcutaneous immunoglobulin market are engaged in the development of subcutaneous human-klhw, an exclusive formulation featuring human immune globulins (Ig) aimed at strengthening the immune system. Subcutaneous human-klhw is intended for subcutaneous administration, designed to treat primary immunodeficiency diseases in the human body. For example, in March 2022, Grifols S.A., a pharmaceutical company based in Spain, launched XEMBIFY 20% subcutaneous immunoglobulin (SCIG). It is specifically formulated to address primary immunodeficiency, fulfilling a crucial medical demand for individuals with impaired immune systems. XEMBIFY is a pre-mixed formulation that simplifies the treatment procedure and enhances convenience for patients. It remains stable at room temperature for up to 24 months, eliminating the need for refrigeration during storage and transportation, which offers considerable advantages in various healthcare settings.

Which Major Industry Participants Are Leading The Subcutaneous Immunoglobulin (SCIG) Market Growth?

Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy’s Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc., Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

How Do Regional Market Performances Compare Within The Subcutaneous Immunoglobulin (SCIG) Industry?

North America was the largest region in the subcutaneous immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Subcutaneous Immunoglobulin (SCIG) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15935&type=smp

Browse Through More Reports Similar to the Global Subcutaneous Immunoglobulin (SCIG) Market 2025, By The Business Research Company

Immunoglobulins Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Intravenous Immunoglobulin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report

Immunoglobulin E Ige Allergy Blood Tests Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoglobulin-e-ige-allergy-blood-tests-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795